"Angina Pectoris" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION.
| Descriptor ID |
D000787
|
| MeSH Number(s) |
C14.280.647.187 C14.907.585.187 C23.888.592.612.233.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Angina Pectoris".
Below are MeSH descriptors whose meaning is more specific than "Angina Pectoris".
This graph shows the total number of publications written about "Angina Pectoris" by people in this website by year, and whether "Angina Pectoris" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 |
| 2002 | 0 | 1 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2016 | 2 | 1 | 3 |
| 2018 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Angina Pectoris" by people in Profiles.
-
Is dyspnea the new angina? The ever-changing profile of patients referred for CAD evaluation. J Nucl Cardiol. 2023 08; 30(4):1321-1323.
-
Contribution of individual components to composite end points in contemporary cardiovascular randomized controlled trials. Am Heart J. 2020 12; 230:71-81.
-
Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials. Eur Heart J. 2018 06 14; 39(23):2208-2216.
-
The effect of tobacco use on outcomes of laparoscopic and open ventral hernia repairs: a review of the NSQIP dataset. Surg Endosc. 2017 06; 31(6):2661-2666.
-
The RENEW Trial: Efficacy and Safety of Intramyocardial Autologous CD34(+) Cell Administration in Patients With Refractory Angina. JACC Cardiovasc Interv. 2016 08 08; 9(15):1576-85.
-
Autologous CD34+ Cell Therapy for Refractory Angina: 2-Year Outcomes From the ACT34-CMI Study. Cell Transplant. 2016; 25(9):1701-1711.
-
The appropriate use of neurostimulation of the spinal cord and peripheral nervous system for the treatment of chronic pain and ischemic diseases: the Neuromodulation Appropriateness Consensus Committee. Neuromodulation. 2014 Aug; 17(6):515-50; discussion 550.
-
Report of a new anomaly of the left anterior descending artery: type VI dual LAD. Catheter Cardiovasc Interv. 2012 Oct 01; 80(4):626-9.
-
Therapeutic angiogenesis for the management of refractory angina: current concepts. Cardiovasc Ther. 2011 Dec; 29(6):e1-e11.
-
Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology-National Cardiovascular Data Registry. Circulation. 2008 Apr 08; 117(14):1787-801.